Norway
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
17.92%
|
Dec. 31, 2023 | USD 15.98 | -1.62% |
|
Norway |
|
2 |
6.28%
|
Dec. 31, 2023 | USD 1.20 | -0.29% |
|
Norway |
|
3 |
-1.56%
|
Dec. 31, 2023 | USD 5.88 | -1.04% |
|
Norway |
|
4 |
-2.45%
|
Dec. 31, 2023 | USD 5.71 | 2.33% |
|
Norway |
|
5 |
-7.26%
|
Dec. 31, 2023 | USD 3.46 | 4.14% |
|
Norway |
|
6 |
-7.59%
|
Dec. 31, 2023 | USD 0.57 | 1.53% |
|
Norway |
|
7 |
-53.10%
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
8 |
-67.73%
|
Dec. 31, 2023 | USD 0.19 | 2.37% |
|
Norway |
|
9 |
-69.67%
|
Dec. 31, 2023 | USD 0.54 | -0.84% |
|
Norway |
|
10 |
-109.51%
|
Dec. 31, 2023 | USD 1.21 | 2.68% |
|
Norway |
|
11 |
-255.06%
|
Dec. 31, 2023 | USD 0.17 | -2.50% |
|
Norway |
The Biotechnology company in Norway with the highest Return on Equity (ROE) is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at 17.92%.
The Biotechnology company in Norway with the lowest Return on Equity (ROE) is Hofseth BioCare ASA (Oslo Stock Exchange: HBC.OL) at -255.06%.
The top 10 Biotechnology companies in Norway by Return on Equity (ROE) are Borregaard ASA, ArcticZymes Technologies ASA, AKVA group ASA, Aker BioMarine AS, Gentian Diagnostics ASA, Salmon Evolution ASA, Lifecare AS, Ultimovacs ASA, NEXT Biometrics Group ASA and Norcod AS.
The bottom 10 Biotechnology companies in Norway by Return on Equity (ROE) are Hofseth BioCare ASA, Norcod AS, NEXT Biometrics Group ASA, Ultimovacs ASA, Lifecare AS, Salmon Evolution ASA, Gentian Diagnostics ASA, Aker BioMarine AS, AKVA group ASA and ArcticZymes Technologies ASA.